BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 16
• 17
• 18
• 19
• 20
• 23
• 24
• 25
• 26
• 27
• 30

• FDA

  NLT SPINE Receives CE Mark for its eSpin; Device and Performs First Clinical Cases in Europe

  April 19, 2012

   · 

  1 min read
• FDA

  FDA Clears GE Healthcare’s PET/CT Quantitative Imaging Technology

  April 19, 2012

   · 

  1 min read
• Business

  Amgen to Assume Some Enbrel Sales Work From Pfizer Inc.; Declined to Say How Many Employees are Affected - Amgen to Hire the Second Half of 2012

  April 19, 2012

   · 

  1 min read
• BioForest

  Alder Biopharmaceuticals Inc. Snags $38 Million to Charge Ahead With Antibody Drugs

  April 19, 2012

   · 

  4 min read
• Drug Development

  Abbott Laboratories Reports Two Hepatitis C Relapses in “Pilot” Trial

  April 19, 2012

   · 

  8 min read
• Drug Development

  Boehringer Ingelheim Corporation Hepatitis C Drugs Cured 82% in Phase II Trial

  April 19, 2012

   · 

  7 min read
• Drug Development

  Medivir AB Hep C Drug Cures 80% of Patients Post-Treatment

  April 19, 2012

   · 

  1 min read
• Bayer Animal Health Release: Garfield Overcomes Fear of the Vet to Beat Cat Kidney Disease

  April 19, 2012

   · 

  5 min read
• Deals

  Cell Therapeutics, Inc. Pays $30 Million in Cash and Stock for S*Bio’s Selective JAK2 Inhibitor

  April 19, 2012

   · 

  10 min read
• Drug Development

  Gilead Sciences, Inc.-Bristol-Myers Squibb Company’s Experimental Hepatitis C Drug Cured 88% Post-Therapy

  April 19, 2012

   · 

  6 min read